Merit Medical Acquires Biolife
Summary Merit Medical Systems has acquired Biolife Delaware for $120 million, adding hemostatic devices StatSeal and WoundSeal to its portfolio. This acquisition expands Merit’s presence in the growing hemostasis market, estimated at $350 million globally. […]
